Folgen
Avishay Edri
Avishay Edri
PhD.
Bestätigte E-Mail-Adresse bei gamida-cell.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers
N Shental, S Levy, V Wuvshet, S Skorniakov, B Shalem, A Ottolenghi, ...
Science advances 6 (37), eabc5961, 2020
1962020
Nanoscale mechanosensing of natural killer cells is revealed by antigen‐functionalized nanowires
G Le Saux, N Bar‐Hanin, A Edri, U Hadad, A Porgador, M Schvartzman
Advanced Materials 31 (4), 1805954, 2019
502019
Inhibition of the NKp44-PCNA immune checkpoint using a mAb to PCNA
K Kundu, S Ghosh, R Sarkar, A Edri, M Brusilovsky, O Gershoni-Yahalom, ...
Cancer immunology research 7 (7), 1120-1134, 2019
272019
Survival in acute myeloid leukemia is associated with NKp44 splice variants
A Shemesh, M Brusilovsky, U Hadad, O Teltsh, A Edri, E Rubin, ...
Oncotarget 7 (22), 32933, 2016
272016
Natural killer cells’ immune response requires a minimal nanoscale distribution of activating antigens
Y Keydar, G Le Saux, A Pandey, E Avishay, N Bar-Hanin, T Esti, ...
Nanoscale 10 (30), 14651-14659, 2018
252018
The Ebola-glycoprotein modulates the function of natural killer cells
A Edri, A Shemesh, M Iraqi, O Matalon, M Brusilovsky, U Hadad, ...
Frontiers in immunology 9, 1428, 2018
232018
Mechanical regulation of the cytotoxic activity of natural killer cells
L Mordechay, G Le Saux, A Edri, U Hadad, A Porgador, M Schvartzman
ACS Biomaterials Science & Engineering 7 (1), 122-132, 2020
212020
Nanowire based mechanostimulating platform for tunable activation of natural killer cells
V Bhingardive, A Edri, A Kossover, GL Saux, B Khand, O Radinsky, ...
Advanced Functional Materials 31 (26), 2103063, 2021
172021
NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint
A Shemesh, A Kugel, N Steiner, M Yezersky, D Tirosh, A Edri, O Teltsh, ...
Oncotarget 7 (43), 70912, 2016
172016
N-Glycans mediate the ebola virus-GP1 shielding of ligands to immune receptors and immune evasion
M Iraqi, A Edri, Y Greenshpan, K Kundu, P Bolel, A Cahana, A Ottolenghi, ...
Frontiers in cellular and infection microbiology 10, 48, 2020
152020
Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI
O Radinsky, A Edri, M Brusilovsky, S Fedida-Metula, A Sobarzo, ...
Scientific Reports 7 (1), 6054, 2017
152017
Molecular-scale spatio-chemical control of the activating-inhibitory signal integration in NK cells
E Toledo, G Le Saux, A Edri, L Li, M Rosenberg, Y Keidar, V Bhingardive, ...
Science advances 7 (24), eabc1640, 2021
142021
Fc-independent protection from SARS-CoV-2 infection by recombinant human monoclonal antibodies
T Noy-Porat, A Edri, R Alcalay, E Makdasi, D Gur, M Aftalion, Y Evgy, ...
Antibodies 10 (4), 45, 2021
112021
Nanowire based guidance of the morphology and cytotoxic activity of natural killer cells
V Bhingardive, G Le Saux, A Edri, A Porgador, M Schvartzman
Small 17 (14), 2007347, 2021
112021
Spatial and chemical surface guidance of NK cell cytotoxic activity
G Le Saux, A Edri, Y Keydar, U Hadad, A Porgador, M Schvartzman
ACS applied materials & interfaces 10 (14), 11486-11494, 2018
102018
Nanocomposite coatings for the prevention of surface contamination by coronavirus
E Toledo, S Dim, A Edri, Y Greenshpan, A Ottolenghi, N Eisner, S Tzadka, ...
Plos one 17 (8), e0272307, 2022
52022
Blocking the PCNA/NKp44 checkpoint to stimulate NK cell responses to multiple myeloma
M Iraqi, A Edri, Y Greenshpan, O Goldstein, N Ofir, P Bolel, M Abu Ahmad, ...
International Journal of Molecular Sciences 23 (9), 4717, 2022
52022
Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors
A Sobarzo, SW Stonier, O Radinsky, S Gelkop, AI Kuehne, A Edri, ...
EBioMedicine 46, 215-226, 2019
42019
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies. Antibodies 2021, 10, 45
T Noy-Porat, A Edri, R Alcalay, E Makdasi, D Gur, M Aftalion, Y Evgy, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
22021
mAb14, a monoclonal antibody against cell surface PCNA: A potential tool for sezary syndrome diagnosis and targeted immunotherapy
J Knaneh, E Hodak, S Fedida-Metula, A Edri, R Eren, Y Yoffe, ...
Cancers 15 (17), 4421, 2023
12023
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20